Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 EUR | +2.77% |
|
-12.11% | +56.81% |
08:00am | Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA | CI |
24/06 | Stifel Cuts Price Target on Nyxoah to $19 From $27, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.81% | 239M | |
+4.25% | 211B | |
+7.51% | 185B | |
+32.11% | 158B | |
+3.16% | 64.32B | |
+20.77% | 55.66B | |
+0.11% | 48.41B | |
-6.43% | 37.82B | |
-0.45% | 35.57B | |
+10.98% | 28.12B |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Stifel Cuts Price Target on Nyxoah to $19 From $27, Maintains Buy Rating